Palliative radiation use for lung cancer higher than advised

This article originally appeared here.
Palliative Radiation Use for Lung Cancer Higher Than Advised
Palliative Radiation Use for Lung Cancer Higher Than Advised

(HealthDay News) -- Half of patients with metastatic non-small-cell lung cancer (NSCLC) receive at least one course of palliative radiation therapy (RT), with younger patients and those who received chemotherapy or surgery more likely to receive palliative RT, according to a study published online Jan. 7 in the Journal of Clinical Oncology.

Aileen B. Chen, M.D., M.P.P., from the Dana-Farber Cancer Institute in Boston, and colleagues investigated population-based patterns in the use of palliative RT among a cohort of 1,574 patients with metastatic NSCLC, diagnosed from 2003 to 2005, using data from the Cancer Care Outcomes Research and Surveillance Consortium study.

The researchers found that 50 percent of the patients received at least one course of RT, 21 percent received RT to the chest, and 12 percent to the bone. Younger age at diagnosis and receipt of chemotherapy and surgery to metastatic sites were factors associated with the use of palliative RT. Six percent of patients receiving palliative bone RT received single-fraction treatment, while 42 percent of those receiving palliative chest RT received more than 20 fractions. Lower doses and fewer fractions to the bone and chest were more likely among patients treated in integrated networks.

"When palliative RT is used in patients with metastatic NSCLC, a substantial proportion of patients receive a greater number of treatments and higher doses than supported by current evidence, suggesting an opportunity to improve care delivery," Chen and colleagues conclude.

One author disclosed financial ties to WellPoint.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs